{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:07:37Z","timestamp":1790179657235,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014764","name":"China International Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014764","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Fujian Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jgar.2026.07.008","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:06:27Z","timestamp":1784909187000},"page":"302-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["In vitro assessment of eravacycline and polymyxin B combination against carbapenem-resistant Klebsiella pneumoniae"],"prefix":"10.1016","volume":"50","author":[{"given":"Shanjian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weizhen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenshuo","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengchao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luoli","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2026.07.008_bib0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000518679","article-title":"Innate host defense against Klebsiella pneumoniae and the outlook for development of immunotherapies","volume":"14","author":"Opoku-Temeng","year":"2022","journal-title":"J Innate Immun"},{"key":"10.1016\/j.jgar.2026.07.008_bib0002","article-title":"Klebsiella pneumoniae clinical characteristics of carbapenem-resistant infection\/colonisation in the intensive care unit: a 9-year retrospective study","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jgar.2026.07.008_bib0003","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.2147\/IDR.S374904","article-title":"Klebsiella pneumoniaeRisk factors for mortality and outcomes in hematological malignancy patients with carbapenem-resistant bloodstream infections","volume":"15","author":"Meng","year":"2022","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.jgar.2026.07.008_bib0004","article-title":"Development of polymyxin- and aminoglycoside-based outer membrane permeabilizers: a review","volume":"16","author":"Danzel Marie","year":"2025","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.07.008_bib0005","article-title":"Molecular characterization of colistin resistance in carbapenem-resistant Klebsiella pneumoniae from a tertiary hospital in China","volume":"13","author":"Saiqi","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2026.07.008_bib0006","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1086\/499819","article-title":"Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America","volume":"42","author":"Talbot","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.008_bib0007","article-title":"Combating resistant pathogens: exploring the efficacy of eravacycline utilization in multidrug-resistant infections","author":"Kiara","year":"2025","journal-title":"Microbiol Spectr"},{"issue":"15","key":"10.1016\/j.jgar.2026.07.008_bib0008","article-title":"Comparison of antimicrobial activities and resistance mechanisms of eravacycline and tigecycline against clinical Acinetobacter baumannii isolates in China","author":"Xiandi","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.07.008_bib0009","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jgar.2022.05.020","article-title":"Synergism of eravacycline combined with other antimicrobial agents against carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii","volume":"30","author":"Li","year":"2022","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.jgar.2026.07.008_bib0010","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"Tamma","year":"2022","journal-title":"Clin Infect Dis: Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jgar.2026.07.008_bib0011","article-title":"Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","author":"Pranita","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.008_bib0012","doi-asserted-by":"crossref","unstructured":"Kade\u0159\u00e1bkov\u00e1 N, Mahmood AJS, Mavridou DAI. Antibiotic susceptibility testing using minimum inhibitory concentration (MIC) assays. Npj antimicrobials and resistance 2024;2:37. https:\/\/doi.org\/10.1038\/s44259-024-00051-6.","DOI":"10.1038\/s44259-024-00051-6"},{"key":"10.1016\/j.jgar.2026.07.008_bib0013","article-title":"Multiplex PCR for detection of acquired carbapenemase genes","volume":"70","author":"Laurent","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.008_bib0014","article-title":"Effect of ceftazidime-avibactam combined with different antimicrobials against carbapenem-resistant Klebsiella pneumoniae","volume":"12","author":"Yun","year":"2024","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2026.07.008_bib0015","first-page":"44","article-title":"Efficacy analysis of intraventricular\/intrathecal polymyxin B sulphate injections in the treatment of post-neurosurgical CNS infections in neurocritical ill patients: a prospective observational study","author":"Jie","year":"2025","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.008_bib0016","doi-asserted-by":"crossref","unstructured":"Yating X., Hongpan T., Qingsong C., Jihong G., Hongmao L., Cuixiang W., et al. Clinical and molecular characteristics of Klebsiella pneumoniae infection in a tertiary general hospital of Wuhan, China. Eur J Clin Microbiol Infect Dis 2023:43. doi:10.1007\/s10096-023-04719-1.","DOI":"10.1007\/s10096-023-04719-1"},{"key":"10.1016\/j.jgar.2026.07.008_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhin.2025.02.003","article-title":"Prognosis analysis and infection-related risk factors of multi-drug-resistant bacteria isolated from a general hospital in China, 2019-2023","volume":"158","author":"Yang","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jgar.2026.07.008_bib0018","article-title":"Global Genomic Epidemiology of Carbapenemase-producing Klebsiella pneumoniae, 1996-2023","author":"Yuxia","year":"2025","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2026.07.008_bib0019","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.gpb.2022.02.005","article-title":"Genomic epidemiology of carbapenemase-producing Klebsiella pneumoniae in China","volume":"20","author":"Li","year":"2022","journal-title":"Genom Proteom Bioinform"},{"key":"10.1016\/j.jgar.2026.07.008_bib0020","doi-asserted-by":"crossref","first-page":"1332458","DOI":"10.3389\/fmicb.2024.1332458","article-title":"Detection and characterization of eravacycline heteroresistance in clinical bacterial isolates","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.jgar.2026.07.008_bib0021","article-title":"Efficiency of combination therapy versus monotherapy for the treatment of infections due to carbapenem-resistant gram-negative bacteria: a systematic review and meta-analysis","volume":"13","author":"Chengcheng","year":"2024","journal-title":"Syst Rev"},{"key":"10.1016\/j.jgar.2026.07.008_bib0022","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jgar.2026.07.008_bib0023","article-title":"Antibacterial activity of eravacycline against Klebsiella pneumoniae isolates: an in vitro study","volume":"13","author":"Yuanzhi","year":"2025","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.jgar.2026.07.008_bib0024","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1093\/jac\/dkae227","article-title":"Epidemiology of carbapenem-resistant Klebsiella pneumoniae in China and the evolving trends of predominant clone ST11: a multicentre, genome-based study","volume":"79","author":"Shi","year":"2024","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526001177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716526001177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:53:08Z","timestamp":1790178788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716526001177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"alternative-id":["S2213716526001177"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2026.07.008","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro assessment of eravacycline and polymyxin B combination against carbapenem-resistant Klebsiella pneumoniae","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2026.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of International Society for Antimicrobial Chemotherapy.","name":"copyright","label":"Copyright"}]}}